Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,112	2,136	1,461	2,895	-	-
Market Cap Growth	-	46.15%	-49.51%	-	-	-
Enterprise Value	1,679	1,792	961	2,387	-242	-63
PE Ratio	-6.51	-6.51	-6.10	-15.52	-	-
PS Ratio	45.38	47.92	36.68	284.42	-	-
PB Ratio	4.36	4.61	3.01	5.33	-	-
P/FCF Ratio	-7.13	-7.13	-12.12	-14.59	-	-
P/OCF Ratio	-7.42	-7.42	-17.50	-18.25	-	-
EV/Sales Ratio	37.66	40.20	24.13	234.51	-60.99	-27.03
EV/EBITDA Ratio	-5.98	-5.98	-4.37	-13.40	2.91	1.06
EV/EBIT Ratio	-5.39	-5.39	-4.01	-12.80	2.78	1.01
EV/FCF Ratio	-5.98	-5.98	-7.97	-12.03	4.72	1.03
Debt / Equity Ratio	0.11	0.11	0.10	0.02	-0.11	-0.10
Debt / EBITDA Ratio	-0.17	-0.17	-0.23	-0.06	-0.27	-0.21
Debt / FCF Ratio	-0.17	-0.17	-0.42	-0.05	-0.44	-0.20
Quick Ratio	4.27	4.27	5.52	11.30	11.44	11.27
Current Ratio	4.70	4.70	5.68	11.46	11.54	11.43
Asset Turnover	0.07	0.07	0.06	0.02	0.02	-
Return on Equity (ROE)	-72.90%	-72.90%	-53.10%	-48.10%	52.60%	-
Return on Assets (ROA)	-50.90%	-50.90%	-35.20%	-33.30%	-43.50%	-
Return on Capital (ROIC)	-68.09%	-68.09%	-45.78%	-33.05%	46.04%	55.87%
Earnings Yield	-16.22%	-15.36%	-16.39%	-6.44%	-	-
FCF Yield	-14.82%	-14.03%	-8.25%	-6.85%	-	-
Buyback Yield / Dilution	-18.41%	-18.41%	-40.04%	-475.48%	-0.98%	-
Total Shareholder Return	-18.41%	-18.41%	-40.04%	-475.48%	-0.98%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).